Legislators
Bills
Statements
Lobbying
Travel
- Bills
- S.250
S.250: Fairness in Orphan Drug Exclusivity Act
About This Bill
- This bill was introduced in the 117th Congress
- This bill is primarily about health
- Introduced Feb. 4, 2021
- Latest Major Action Feb. 4, 2021
- See the one similar bills introduced in other congresses.
Bill Sponsor
Bill Version
- Introduced in Senate - Feb. 4, 2021
Bill Summary
Fairness in Orphan Drug Exclusivity Act This bill limits which orphan drugs may be granted a market exclusivity period by the Food and Drug Administration (FDA). (Generally, an orphan drug is one that is not economically viable because of the rarity of the disease that it treats; the sponsor of an FDA-designated orphan drug may be granted various incentives, such as a seven-year period in which the FDA may not grant market approval to a...
(Source: Library of Congress)
Bill Actions
Date | Description |
---|---|
Feb. 4, 2021 |
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
|
Feb. 4, 2021 |
Introduced in the Senate by Bill Cassidy (R-La.) |